Sphera Funds Management Ltd. Clearside Biomedical, Inc. Transaction History

Sphera Funds Management Ltd.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 15, 2019	SELL	$1.1 - $1.74 $1.3 Million - $2.06 Million	-1,185,124 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$1.0 - $6.12 $30,434 - $186,256	30,434 Added 2.64%	1,185,124 $1.27 Million
Q3 2018 Nov 14, 2018	BUY	$6.03 - $11.24 $518,399 - $966,302	85,970 Added 8.04%	1,154,690 $7.1 Million
Q2 2018 Aug 13, 2018	BUY	$8.91 - $14.54 $344,995 - $562,988	38,720 Added 3.76%	1,068,720 $11.4 Million
Q1 2018 May 10, 2018	BUY	$5.57 - $14.28 $3.23 Million - $8.28 Million	580,000 Added 128.89%	1,030,000 $11.1 Million
Q4 2017 Feb 12, 2018	BUY	$5.78 - $9.12 $867,000 - $1.37 Million	150,000 Added 50.0%	450,000 $3.15 Million
Q3 2017 Nov 09, 2017	BUY	$6.73 - $8.74 $2.02 Million - $2.62 Million	300,000	300,000 $2.62 Million

12.2M

54.7K

50.7K

Ticker CLSD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,190,700
Market Cap $59.6M
Description
Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injec...

Get notified when there are updates to the investment portfolio of Sphera Funds Management Ltd., based on Form 13F filings with the SEC.

Stay updated on Sphera Funds Management Ltd. with notifications on news.